ABBVIE INC.
Market cap $514.9B
$291.31
ABBV
$291.31
+1.07% today
Buy with €1M virtual cash · No real money
ABBVIE INC. (ABBV) is a publicly traded company listed on the XNYS. As of November 8, 2026, Invest's signal rates ABBV a Buy, with the stock up 34% over the past year. You can practice trading ABBV risk-free with €1,000,000 in virtual cash.
Key stats
As of November 8, 2026
Market Cap
$514.9B
Volume
5.0M
52-wk High
$302.93
52-wk Low
$190.75
Day High
$291.73
Day Low
$281.07
Performance
1M
+6.9%
6M
+44.5%
1Y
+34.4%
Invest signal · ABBV
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
ABBV overview
AI overviewLatest ABBV news
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
The Motley Fool · 23h ago
Moderna (MRNA) Stock Hits 52-Week Highs After Q3 Earnings: Buy, Hold, or Sell?
Zacks Investment Research · 1d ago
IRWD Q3 Earnings Beat, Revenues Miss, 2026 View Raised, Stock Up
Zacks Investment Research · 1d ago
JNJ's Innovative Medicine Unit Grows in Q3 Despite Patent Losses
Zacks Investment Research · 1d ago
2 Defensive Healthcare Stocks Hitting New 52-Week Highs: ABBV & LLY
Zacks Investment Research · 2d ago
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox.
The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.
Employees
57,000
30-Day Win Rate · ABBV
15 days
9 days
Last 24 sessions
How to practice trading ABBV
- 1
Use the ABBV buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top ABBV traders on Invest
Full leaderboardFrequently asked questions
Is ABBV a good stock to buy right now?
As of November 8, 2026, Invest's signal rates ABBV a Buy, based on its price trend, valuation, and fundamentals, with the stock up 34% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading ABBV risk-free first.
What is ABBVIE INC.'s (ABBV) market cap?
ABBVIE INC. has a market capitalization of approximately $514.9B.
How has ABBV stock performed?
ABBV is up 34% over the past year and up 45% over six months. Its 52-week range runs roughly from $190.75 to $302.93. Past performance doesn't predict future results.
How can I practice trading ABBV for free?
On Invest you get €1,000,000 in virtual cash and can buy ABBV at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare ABBV with peers